Tag Archives: Pharmacology

Arachidonic acid: a very important fatty acid

Arachidonic acid is a fatty acid (a carboxylic acid with a long carbon tail) with 20 carbons and 4 double bonds. Counting from the end without the carboxylic acid group, the first double bond appears at the 6th position from the end, making this an omega-6 fatty acid.

Chemical structure of arachidonic acid. Credits: Wikimedia (Public domain) https://commons.wikimedia.org/wiki/File:AAnumbering.png

Arachidonic acid is incorporated into phospholipids in cell membranes. In the process of some cell signalling events such as the inflammatory cascade, it is cleaved from phospholipids by phospholipase A2 (PLA2), after which it can be modified into many signalling molecules including the prostaglandins (PGs), thromboxanes (TXs), and leukotrienes (LTs). These are the most well-known and well-studied of the metabolites derived from arachidonic acid; however, there are also many other compounds including the endocannabinoids (ECs), and several less understood groups such as the eoxins (EXs)lipoxins (LXs), epoxyeicosatrienoic acids (EETs), hepoxilins (HXs), isoprostanes (IsoPs), and isofurans (IsoFs). Some of these compounds are quite recent discoveries and thus have little information available about them. Nevertheless, many of these compounds have biological activity associated with the inflammatory response, either with anti-inflammatory or pro-inflammatory effects. The latter molecules are still under active investigation in order to better understand the way they mediate actions in the body. [1]

The actions of all these molecules are too numerous to explain here. Some of the most well-known actions are those of the prostaglandins. If you have ever taken NSAIDs such as ibuprofen or naproxen, you will have affected this system. These drugs inhibit the cyclooxygenase enzyme, a critical enzyme in prostaglandin synthesis. Prostaglandins have diverse effects such as acting as pro-inflammatory mediators and regulating smooth muscle contraction and relaxation (such as PGE2), or causing vasodilation and preventing platelet aggregation (such as PGI2, also known as prostacyclin). Other molecules in the cyclooxygenase pathway, such as thromboxane, promote clotting and causing blood vessels to contract (such as TXA2). [2] The leukotrienes, synthesized from the lipooxygenase pathway, are inflammatory mediators. Some asthma medications, such as montelukast and zafirlukast, block the actions of the leukotriene LTD4 which can help with the bronchospasms in asthma. [3]

The endocannabinoid system is also a growing area of interest. The compound N-arachidonoylethanolamine, also known as anandamide, is probably the most well-known compound. The effects of this compound include pain sensation modulation, reward processes in the brain, and immune system modulation. [4]

This is only a small peek at the world of arachidonic acid metabolites: there remains much to be explained outside of this blog post, and much to be discovered!

Sources:

[1] Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., Hu, J., Fleming, I., & Wang, D. W. (2021). Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets. Signal Transduction and Targeted Therapy, 6(1), 1–30. https://doi.org/10.1038/s41392-020-00443-w
[2] Ricciotti, E., & FitzGerald, G. A. (2011). Prostaglandins and inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(5), 986–1000. https://doi.org/10.1161/ATVBAHA.110.207449
[3] Dempsey, O. J. (2000). Leukotriene receptor antagonist therapy. Postgraduate Medical Journal, 76(902), 767–773. https://doi.org/10.1136/pmj.76.902.767
[4] Lu, H.-C., & Mackie, K. (2016). An Introduction to the Endogenous Cannabinoid System. Biological Psychiatry, 79(7), 516–525. https://doi.org/10.1016/j.biopsych.2015.07.028

Hydrogels as an Ophthalmic Drug Delivery System

If you’ve ever had some sort of eye surgery, you might have been prescribed an assortment of eyedrops with their own frequent dosing schedules. The reason for the frequent dosing is that topical drug delivery to the eye is quite difficult, and upon further evaluation this should make sense! The eye is a delicate structure that has many barriers to prevent the entry of foreign particles. Hydrogel technology has been heavily investigated as a sustained drug release vehicle, obviating the need for such frequent dosing.

barriers of the eye

Drug residence time delivered via eye drops can be cut short due to pre-corneal factors: tears, blinking, and drainage through the nasolacrimal duct. Some of you might have been told to pinch the bridge of your nose after administering eye drops, this is to block off the drug from draining through this duct into the nose. In addition, drug that does remain on the eye must penetrate through the thick multi-layered cornea to get to the deeper tissues of the eye. The conjunctiva at the surface of the eye is also highly vascularized, meaning the drug will also be absorbed into the bloodstream before penetrating through the eye.

Anatomy of the eye. Credits: American Academy of Ophthalmology

Drainage through the nasolacrimal duct and absorption through the highly vascularized conjunctiva may cause unwanted side effects, as the drug is being distributed to off-target tissues through the circulatory system. Ironically, drugs cannot be delivered via consumption or systemic injection as there are blood-ocular barriers (analogous to the blood-brain barrier) that prevent systemic distribution of drugs to ocular tissue.

hydrogels to the rescue!

Hydrogels are basically polymers (long chemical chains) composed 95% of water. The advantage of hydrogels is that they are viscous, meaning that they can stick onto the eye longer before being removed. They can also encapsulate drug molecules, and can release the desired drug at a certain rate, based on their initial preparation conditions. Currently, there are many types of hydrogels being investigated for there use in drug delivery. These can be broken down into synthetic polymers, which have the advantage of being easily tunable in mechanical properties and natural polymers, which have the advantage of being biocompatible to the eye. In-situ forming hydrogels have been an area of focus, as they can be administered as a liquid, but gels in response to a stimulus. For example a gel could be liquid at room temperature but turn into a gel at body temperature.

Despite being a potential solve to a long-standing problem, there is currently no FDA-approved hydrogel used in drug delivery. A lot more research in terms of in vitro, in vivo, and clinical studies are needed to evaluate the long-term efficacy and biocompatibility of these options. However, hydrogels have made their way into clinical use in other ophthalmic departments! An immediate one that comes to mind is the use of contact lenses which are practically just hydrogels. A lesser known use is in cataract surgery, where hydrogels have been used as ocular adhesives to seal any surgery-induced wounds.

References

Lynch, C.R.; Kondiah, P.P.D.; Choonara, Y.E.; du Toit, L.C.; Ally, N.; Pillay, V. Hydrogel Biomaterials for Application in Ocular Drug Delivery. Front. Bioeng. Biotechnol. 2020, 8, 228, doi:10.3389/fbioe.2020.00228.